Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma
Clinical trial NCT02916420 · UNKNOWN
Trial details
- NCT number
- NCT02916420
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2018-06-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.